Search Results

The ONE Snare Endovascular Microspare System is intended for use in adult and pediations for the retrieval and manipulation of atraumatic foreign bodies located in the coronary and peripheral cardiovascular system and the extracranial anatomy.

ONE Snare Endovascular Microsnare System contains: (1) Snare, (1) Snare Catheter, (1) Insertion Tool and (1) Torque Device. The snare is constructed of nitinol cable and a gold plated tungsten loop. The pre-formed snare loop can be introduced through catheters without risk of snare deformation because of the snare's super-elastic construction. The snare catheter is constructed of polyether block amide (Pebax®) and contains a platinum/iridium radiopaque marker band.

The provided text describes the 510(k) premarket notification for the ONE Snare Endovascular Microsnare System. However, it does not explicitly define acceptance criteria or specific study results in the format requested. The document primarily lists performance attributes that were tested to demonstrate substantial equivalence to predicate devices, rather than providing quantitative acceptance criteria and corresponding detailed device performance data.

Based on the information available:

1. Table of Acceptance Criteria and Reported Device Performance

The document does not provide a table with specific numerical or quantitative acceptance criteria and corresponding performance metrics for the ONE Snare Endovascular Microsnare System. Instead, it lists a comprehensive set of tests performed and states that these tests were "successfully completed" or "designed to demonstrate that the device meets critical design specifications as well as clinical performance attributes for its intended use."

The identified performance attributes tested include (but are not limited to):

The document implies that the device "meets critical design specifications as well as clinical performance attributes for its intended use" by successfully completing these tests, but the specific numerical "acceptance criteria" and "reported device performance" are not detailed.

2. Sample Size Used for the Test Set and Data Provenance

The document does not specify the sample size used for any of the tests conducted. It also does not provide information on data provenance (e.g., country of origin, retrospective or prospective) as the studies appear to be bench and laboratory-based performance tests rather than clinical studies with patient data.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Experts

This information is not applicable as the studies described are in vitro or bench tests, not clinical studies requiring expert interpretation of medical images or patient outcomes for ground truth establishment.

4. Adjudication Method for the Test Set

This information is not applicable for the same reasons as #3.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size

No MRMC comparative effectiveness study is mentioned in the provided text. The studies focus on the device's physical and functional performance and biocompatibility.

6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Was Done

This question is not applicable as the device is a physical medical instrument (an endovascular microsnare system), not an algorithm or AI software. There is no "algorithm only" performance to evaluate.

7. The Type of Ground Truth Used

For the performance tests described (e.g., tensile strength, corrosion resistance, biocompatibility), the "ground truth" would be objective measurements and established standards (e.g., ISO, ASTM, FDA guidance documents). The tests were designed to demonstrate adherence to critical engineering specifications and regulatory requirements.

8. The Sample Size for the Training Set

This is not applicable as the device is a physical medical device, not an AI model requiring a training set.

9. How the Ground Truth for the Training Set Was Established

This is not applicable for the same reasons as #8.

Summary of Study Type:

The studies described are a series of bench testing, laboratory testing, and biocompatibility assessments to demonstrate the physical, chemical, and functional performance of the ONE Snare Endovascular Microsnare System. The purpose of these tests was to establish substantial equivalence to predicate devices under the 510(k) pathway, not to evaluate clinical efficacy or diagnostic accuracy using patient data or expert adjudicated ground truth. The acceptance of the device is based on its ability to perform robustly under various conditions and meet recognized standards (e.g., ISO, ASTM) and design specifications.

Ask a specific question about this device